The most common presentations of CTLA-4 inhibitor-related IH are FSH and/or LH deficiency (88%) and TSH deficiency (81%), followed by ACTH deficiency (55%) [38]. The gene discussed is CTLA4; the disease is isolated hemihyperplasia.